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Abstract The crystal structure of a recombinant human a 1- 
antitrypsin, in the uncleared and uneomplexed state, has been 
determined by X-ray crystallographic methods and refined to an 
R-factor of 18.4% for 8.0-3.46 A data with good stereocbemistry. 
This structure provides the first view at the inhibitory loop and 
the central/S-sheet A of the uncleared ch-antitrypsin. The reac- 
tive loop takes a distorted helical conformation and no pre-inser- 
tion of two residues in the reactive loop into the O-sbeet A is 
observed. The present structure is largely in agreement with the 
model predicted by Engh, Wright, and Huber [Prot. Eng. 3 (1990) 
469-4771. 
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1. Introduction 
The serpins (serine proteinase inhibitors) are a ubiquitous 
family of proteins with diverse functions [1]. They include the 
proteinase inhibitors of human plasma as well as non-inhibitory 
plasma proteins [2]. Inhibitory serpins bind to their target en- 
zymes through the reactive site, denoted as P1-PI'  according 
to the nomenclature of Schecter and Berger [3], which contains 
the carboxyl and amino-groups, respectively, of the scissile 
peptide linkage. Serpins share a common tertiary structure with 
three fl-sheets (A-C) and nine a-helices (A-I) [2]. However, the 
conformations of the reactive loop show striking variations. 
And known serpin structures have been grouped into four 
discrete classes: uncleaved non-inhibitory, cleaved at the P I -P I '  
junction, active, and latent [4]. 
Human a~-antitrypsin (abbreviated here as a~AT and also 
known as ~z~-proteinase inhibitor), a member of the serpin fam- 
ily, is a glycoprotein of 394 residues. Its genetic deficiency is 
associated with the lung and liver diseases: for example, the Z 
variant (Glu342--~Lys) leads to emphesyma [5]. A recent study 
revealed that the Z variant is defective because it folds slowly 
into the native confomation [6]. The first X-ray structure of 
inhibitory serpin, that of cleaved a~AT, showed an unexpected 
separation of its reactive center peptide bond (Met358-Ser359) 
by about 70 ]k with incorporation of the reactive loop into 
fl-sheet structures [7]. The structure of the intact ~AT has been 
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sin; r.m.s., root mean square; 9api*, modified a~-antitrypsin with the 
reactive loop (P15-P5', residues 344-363) removed. 
modeled based on the assumption that the central strand s4A 
of the fl-sheet A of the cleaved inhibitor is removed from the 
sheet in the intact inhibitor [8]. This modeling was supported 
by the X-ray structure of plakalbumin. Here we report the 
crystal structure of a recombinant human a tAT in its uncleaved 
and uncomplexed state. This provides the first view at the 
reactive loop and the central fl-sheet of the uncleaved ~AT.  
2. Materials and methods 
The recombinant human a~AT was purified as described previously 
[9]. For the crystallization purpose, the purified inhibitor was concen- 
trated to 10 mg/ml by ultrafiltration and then dialyzed against 50 mM 
Tris-HCl buffer (pH 7.90). Crystallization was achieved by the hanging 
drop vapor diffusion method at room temperature (22-23°C). Hanging 
drops were prepared by mixing equal volumes of the protein and the 
reservoir solutions. Single crystals were grown when the reservoir solu- 
tion contained 28.5% (w/v) polyethylene glycol 4000, 100 mM Tris-HCl 
(pH 8.50), and 200 mM lithium sulfate. X-ray data were collected on 
a FAST TV-area detector (Enraf-Nonius), using the MADNES soft- 
ware [10]. Graphite-monochromatized CuK~ X-rays from a rotating 
anode generator (Rigaku RU-200), running at 40 kV and 70 mA, were 
used with a 0.3 mm focus cup and a 0.6 mm collimator. The reflection 
intensities were obtained by the profile fitting procedure of Kabsch [11] 
and the data were scaled by the Fourier scaling program [12]. The 
crystal belongs to the monoclinic space group C2 with unit cell dimen- 
sions of a = 114.87 A, b = 39.98 •, c = 92.42 A, and fl = 102.82 °. 
There is one cqAT molecule in the asymmetric unit (V M = 2.34 A3/Da; 
solvent content = 48%). The completeness of the data set is 81.2% 
between 35.0 and 3.46 A, with the data between 3.60 and 3.46 A being 
63.0% complete. 
The structure of a~AT was determined by molecular eplacement 
methods [13,14] using the program package X-PLOR [15] and AMoRe 
(an Automated package for Molecular Replacement) [16]. Four models 
were investigated for the molecular replacement: cleaved a~AT (pdb ID 
code: 9api, R-factor = 20.9% at 3.0 A resolution) [7], modified ~AT 
with the reactive loop (P 15-P5', residues 344-363) removed (denoted as 
9api*), cleaved 0q-antichymotrypsin (pdb ID code: 2ach, R-fac- 
tor-- 18.7% at 2.7 A resolution) [17], and ovalbumin (pdb ID code: 
lova, R-factor = 16.9% at 1.95 A resolution) [18]. For molecular e- 
placement calculations, only the non-hydrogen protein atoms in the 
model were included. A 2a cutoff based on F was applied to the data 
throughout he molecular eplacement and refinement calculations, 
unless otherwise noted. The probe structure factors were calculated by 
placing the starting model in an orthogonal cell with dimensions 100 
× 100 A × 100 A. A consistent solution was obtained with the four 
starting models and for different resolution ranges. The results of the 
molecular replacement calculations using AMoRe are summarized in
Table 1. 
The 9api* model, with the inhibitory loop (PI5-P5', residues 344- 
363) removed from the cleaved a~AT, gave the highest correlation 
coefficient among the four models (Table 1). After orienting and posi- 
tioning the 9api* model according to the molecular replacement solu- 
tion, the model was subject to refinement by the program package 
X-PLOR [15]. Initially a rigid-body refinement was carried out to fur- 
ther improve the values of the positional and orientational parameters. 
The resolution range of the diffraction data was increased stepwise 
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Table 1 
A ~ummary of AMoRe results" 
151 
M~,del b Peak Rotation (o) 
(pt!b 1D) rank 
Translation R-factor 
(%) 
/~ r x z 
Correlation 
coefficient 
9a,i 
9a ~i* 
2a h 
lo 'a 
~1.: 04.5 ]~ data 
1 295.03 63.97 53.94 0.319 0.251 47.6 0.436 
2 214.96 34.47 68.63 0.445 0.021 53.8 0.292 
1 296.04 61.33 53.22 0.324 0.252 47.2 0.458 
2 26.39 42.23 160.91 0.087 0.381 52.8 0.255 
1 282.98 80.48 236.95 0.318 0.248 43.8 0.424 
2 207.14 42.08 257.55 0.230 0.424 47.3 0.352 
1 296.45 67.50 53.26 0.322 0.244 48.5 0.419 
2 175.54 39.93 256.25 0.306 0.384 52.2 0.267 
were used. 
b9~ pi: cleaved ~l-antitrypsin, 9api*: modified arantitrypsin with the reactive loop (PI5-P5', residues 344-363) removed, 2ach: cleaved a~-antichymo- 
trx psin, lova: uncleaved ovalbumin. The number of strands in the central fl-sheet A in each model is six for 9api and 2ach and five for 9api* and 
l o ,a. 
from 8.0-5.0 to 8.0-3.5/k. The atomic B-factors in the initial model were 
then changed to 20.0/k 2and this value was kept during the next rounds 
of "efinement. The refinement of positional parameters by conventional 
conjugate gradient minimization reduced the R-factor from 41.4 to 
27 8% (Table 2). The electron density maps calculated with amplitude 
coefficients 2Fo-Fc and Fo-F ~ were used as guides for manual rebuild- 
in~: of the model using the computer program CHAIN [19]. At this stage 
the inhibitory reactive loop could be built into the electron density. 
Finally the model was subject o another ound of positional refine- 
meat, followed by simulated annealing refinement [20]. The course of 
cr~ stallographic refinement is summarized in Table 2. Structural com- 
parisons were made using the program LSQKAB in CCP4 program 
pa~-kage [21]. 
3. Results and discussion 
Fhe refined model contains 2,965 non-hydrogen protein 
at,,ms accounting for 375 amino acid residues of uncleaved 
cz~ X_T and no solvent atoms (Fig. 1). The missing residues are 
the N-terminal 19 residues, which are also missing in the start- 
in:: model. Final crystallographic R-factor is 18.4% for 4,079 
unique reflections in the 8.0-3.46/~ resolution range with F > 
2av. The r.m.s, deviations from ideal stereochemistry are 0.015 
A for bond lengths, 2.44 ° for bond angles, 26.4 ° for dihedral 
angles, and 1.9 ° for improper angles. When the refined model 
is compared with the starting model (9api*), the r.m.s, deviation 
for 355 Ccz atom pairs (residues 20-343 and 364-394) is 1.8/~. 
This indicates that a model bias that is inherent in the molecular 
replacement solution has been sufficiently reduced during the 
refinement. As anticipated, the central fl-sheet A shows the 
largest deviation resulting from the closure of the gap between 
the strands s3A and s5A in the starting model (Fig. 1). 
The most pronounced structural difference between the un- 
cleaved and cleaved ~AT is in the conformation of the reactive 
loop. The reactive loop of the uncleaved cqAT, absent in the 
starting model, is clearly defined by the electron density. As an 
example, an omit map for a part of the inhibitory loop is shown 
in Fig. 2. A nearly continuous electron density is observed from 
Glu354 (P5' residue) to Glu363 (P5 residue). The reactive loop 
adopts a distorted helical conformation in the uncleaved cqAT 
Table 2 
Tb ~ course of crystallographic refinement 
St~ ge Resolution R-factor ~ R.m.s. deviation Comments 
range (A) (%) 
Bond length (/k) Bond angle (o) 
1 15.04.5 47.2 0.016 2.07 
2 8.0-3.5 48.0 
3 8.0-3.5 44.0 
4 8.0-3.5 41.4 
5 8.0-3.5 30.0 0.017 2.37 
6 8.0-3.5 27.8 0.016 2.25 
7 
8 8.0-3.5 24.8 0.015 2.42 
9 8.0-3.5 22.7 0.015 2.38 
10 
11 8.0-3.46 20.0 0.016 2.50 
12 8.0-3.46 20.7 0.015 2.35 
13 8.0-3.46 18.4 0.015 2.44 
~Rcflections with F o > 2av. 
AMoRe solution (9api *a) 
Rigid-body refinement (1 rigid group) 
Rigid-body refinement (23 rigid groups) 
Rigid-body refinement (36 rigid groups) 
Positional refinement 
Positional refinement 
Manual model rebuilding 
Positional refinement 
Positional refinement 
Manual model rebuilding 
Positional refinement 
Prepstage refinement 
Simulated annealing refinement 
"(9api*) Starting model: cleaved ~-antitrypsin with the reactive loop (P15-P5', residues 344-363) removed. 
bAt this stage atomic B-factors in the starting model were changed to 20.0 A 2 and this value was kept for the next rounds of refinement (stages ~13). 
~The reactive loop (P15-P5', residues 344-363) was built using 2Fo-F c and Fo-F  c electron density maps. 
aThe problematic regions in the model were rebuilt using 2F o -F  c and F o -F  c electron density maps. 
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Fig. 1. Stereo ribbon diagram of uncleaved a~AT drawn with the program MOLSCRIPT [22]. The a-helices are represented by helical ribbons and 
fl-sheets by arrows. The reactive loop residues P15-P5' (Gly344-Glu363) are at the top. 
(Fig. 1, top). The observed conformation of the reactive loop 
is largely in agreement with the model predicted by Engh, 
Wright, and Huber [8]. A similar conformation of the reactive 
loop was also found in a recombinant a~-antichymotrypsin [23]. 
In comparison, the reactive loop of ovalbumin, an intact non- 
inhibitory serpin, takes a helical conformation. Further varia- 
tions of the reactive loop have been observed in the crystal 
structure of antithrombin, for which one active molecule has 
its partially inserted reactive loop in the central fl-sheet A 
(termed 'pre-insertion') and the other inactive molecule has a 
totally incorporated loop as in latent plasminogen activator 
inhibitor-1 [24,25]. 
A comparison of the central fl-sheet A (lying vertically in 
Figs. 1 and 3) in the uncleaved alAT with those in other struc- 
tures of serpins reveals interesting differences as well as similar- 
ities. In the uncleaved ~zlAT, the strand s4A offl-sheet A in the 
cleaved a~AT is removed from the sheet (Fig. 3a). A superpos- 
ition of 54 Ca atoms in the central fl-sheet A [s2A (residues 
109 121), s3A (residues 181-194), s5A (residues 326-342), and 
s6A (residues 290 299)] of the present model of uncleaved 
~AT and the corresponding atoms in the cleaved ~AT model 
(9api) gives an r.m.s, difference of 2.4 A (Fig. 3a). In contrast, 
a superposition of the above 54 Ca pairs in the uncleaved a~AT 
and ovalbumin (lova) gives a much smaller .m.s, difference of 
Met358 et358 
59 59 
Fig. 2. An (Fo-Fc) omit map for a part of the reactive loop, contoured at 2.5 a. The map was generated using data in the range 8.0-3.46 A and phases 
calculated from the current model with ten residues P5-P5' (Glu354-Glu363) omitted. The refined model of the omitted region is drawn in thick lines 
and P1 Met358 and PI' Ser359 are indicated. Other parts of the model are drawn by Ca tracings in thin lines. 
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(a) (b) 
Fi~. 3. A stereo view of the final (2Fo-Fc) electron density map and the central f -sheet A of uncleaved ~IAT (in thick lines). The reactive loop of 
un,.:leaved c~]AT is also shown at the top of the figure. Thin lines in (a) and (b) represent the superposed models of cleaved ~zAT and ovalbumin, 
respectively. The strands of the central f -sheet A are labelled as s2A, s3A, s4A, s5A, and s6A, respectively. The P15, P1, and P5' sites of the reactive 
lo~.ps are also indicated. 
1.~ /k (Fig. 3b). Thus it is found that the central fl-sheet A of 
the* uncleaved ~IAT is largely similar to that of ovalbumin. This 
is ,~asily understood because the N-terminal part of the reactive 
lo,,p in the cleaved ~LAT structure is fully inserted into the 
cel~tral f -sheet A to form the strand s4A, whereas the reactive 
lo,,p in ovalbumin forms a helix at the top of the molecule, 
le~ving fl-sheet A with one less strand (Fig. 3b). The reactive 
lo~,p of the uncleaved ~IAT, adopting a distorted helical con- 
formation, lies a little closer to the main body than that of 
o~albumin (Fig. 3b). This may be partly due to the crystal 
pa~zking. The reactive loop of our uncleaved cqAT makes a 
'h~ ad-to-head' contact with a symmetry-related molecule in the 
cr~ stal. 
Xnother example of serpin for which both the intact and 
cleaved structures are known is antithrombin. A superposition 
of 61 Cc~ atom pairs in the central fl-sheet A, excluding the very 
dilferent reactive loop, gives an r.m.s, difference of 1.7 ~ [26]. 
This intermediate difference is a consequence of the wider 
opening between the strands s3A and s5A in the fl-sheet A, 
which allows a partial insertion of two s4A residues. In con- 
trast, no pre-insertion of the two N-terminal residues of the 
reactive loop is observed for the uncleaved ~AT in this study 
as well as for the uncleaved ej-antichymotrypsin [23]. 
In summary, the present structure, albeit at a somewhat low 
resolution, shows for the first time that the reactive loop of 
uncleaved ~IAT in the uncomplexed state adopts a distorted 
helical conformation and no pre-insertion of two s4A residues 
into the central fl-sheet A takes place. 
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